Circulating Fatty Acid-Binding Protein 4 (FABP4) in Adolescents with Polycystic Ovary Syndrome: Metabolic Correlates and Diagnostic Performance
- 14 September 2026
- journal article
- research article
- Published by Springer Nature in Reproductive Sciences
- p. 1-12
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndromeEuropean Journal of Endocrinology, 2023
- Several Circulating Biomarkers for PCOS DiagnosisExperimental and Clinical Endocrinology & Diabetes, 2019
- Curtailing PCOSPediatric Research, 2019
- The diagnosis and treatment of PCOS in adolescents: an updateCurrent Opinion in Pediatrics, 2019
- New biomarkers for diagnosis and management of polycystic ovary syndromeClinica Chimica Acta, 2017
- Associations between adipocyte fatty acid-binding protein and clinical parameters in polycystic ovary syndromeArchives of Gynecology and Obstetrics, 2014
- Adipocyte fatty acid binding protein: a novel adipokine involved in the pathogenesis of metabolic and vascular disease?Diabetologia, 2012
- Expression and regulation of adipocyte fatty acid binding protein in granulosa cells and its relation with clinical characteristics of polycystic ovary syndromeEndocrine, 2011
- FABP4: a novel candidate gene for polycystic ovary syndromeEndocrine, 2009
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)Human Reproduction, 2004